P0758 Comparative risk of nephrolithiasis in obesity pharmacotherapy: A real-world analysis of semaglutide, tirzepatide, and orlistat in type 2 diabetes

European Urology 2026

View at publisher

Authors: P-H. Lee, Y.H. Chen, C.J. Liu

DOI: 10.1016/s0302-2838(26)01626-x

Cited by: 0

Fields of Study & Subjects

Kidney Stones and Urolithiasis Treatments Pharmacology and Obesity Treatment Diabetes Treatment and Management